News for 'SAR technologies'

Zydus's India-made Covid vaccine gets emergency use approval

Zydus's India-made Covid vaccine gets emergency use approval

Rediff.com20 Aug 2021

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance

How monkeys were tracked for Covaxin trial

How monkeys were tracked for Covaxin trial

Rediff.com14 Nov 2021

The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.

MoD signs Rs 19,600 cr deal for 17 India-made next-gen patrol, missile ships

MoD signs Rs 19,600 cr deal for 17 India-made next-gen patrol, missile ships

Rediff.com30 Mar 2023

In line with the government's vision of 'Aatmanirbhar Bharat', the ministry of defence on Thursday signed contracts with Indian shipyards for the acquisition of 11 next generation offshore patrol vessels and six next generation missile vessels at a cost of nearly Rs 19,600 crore, officials said.

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

Covid 3rd wave likely this month, may peak in Oct: Report

Covid 3rd wave likely this month, may peak in Oct: Report

Rediff.com2 Aug 2021

The next wave is likely to be far smaller than the second wave that peaked at a record 400,000-plus daily cases on May 7 and declined sharply thereafter.

Pune's NIV develops ELISA test to detect COVID-19 antibodies

Pune's NIV develops ELISA test to detect COVID-19 antibodies

Rediff.com10 May 2020

The test kit has the advantage of testing 90 samples together in a single run of 2.5 hours, so that healthcare professionals can proceed quickly with necessary next steps.

Unwarranted to think COVID-19 will vanish in summer: Virologist

Unwarranted to think COVID-19 will vanish in summer: Virologist

Rediff.com11 May 2020

The arrival of summer in India may have raised hopes that hot and humid weather could slow the COVID-19 progression but virologist Naga Suresh Veerapu believes that outbreak and pandemic occurrences often do not follow seasonality.

Centre studies if coronavirus present in Ganga water

Centre studies if coronavirus present in Ganga water

Rediff.com8 Jun 2021

The Centre is conducting a study to assess the presence of SARS-CoV-2, or novel coronavirus, in the Ganga as corpses were found dumped in the river during the second Covid wave, and were fished out from districts in Uttar Pradesh and Bihar, officials said.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

New smartphone-based COVID test gives results in less than 30 minutes

New smartphone-based COVID test gives results in less than 30 minutes

Rediff.com7 Dec 2020

The research found that the device accurately detected a set of positive samples in under 5 minutes.

Full Text: PM Modi's address to US Congress

Full Text: PM Modi's address to US Congress

Rediff.com23 Jun 2023

Here's the full text of Prime Minister Narendra Modi's address to a joint session of the United States Congress, delivered on Thursday.

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Rediff.com22 Mar 2022

Noting that various mathematical models meant for predicting coronavirus waves have repeatedly failed to give reliable results due to a small sample size, the Centre on Tuesday said it is closely following the virus trajectory globally, given the emergence of its new variants.

Perfect lift off! ISRO launches 2 foreign earth observation satellites

Perfect lift off! ISRO launches 2 foreign earth observation satellites

Rediff.com17 Sep 2018

The polar satellite launch vehicle-C42 launch vehicle carrying the two satellites blasted off from the first launchpad at the Satish Dhawan Space Centre at 10.08 pm.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

Covaxin's 50 pc efficacy adequate for Covid, say experts

Covaxin's 50 pc efficacy adequate for Covid, say experts

Rediff.com26 Nov 2021

The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.

Kerala institute develops kit to detect COVID-19 in 2 hrs: Vardhan

Kerala institute develops kit to detect COVID-19 in 2 hrs: Vardhan

Rediff.com18 Apr 2020

The diagnostic test kit developed by the Thiruvananthapuram institute can detect coronavirus in 10 minutes, and the sample to result time will be less than two hours, Vardhan tweeted. A total of 30 samples can be tested in a single batch on a single machine, he said.

With Omicron, 3rd wave projected to hit India by Feb

With Omicron, 3rd wave projected to hit India by Feb

Rediff.com6 Dec 2021

With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.

Report indicates Wuhan scientists got sick with Covid before outbreak

Report indicates Wuhan scientists got sick with Covid before outbreak

Rediff.com24 May 2021

Three researchers from the Wuhan Institute of Virology sought hospital care in November 2019, weeks before Beijing disclosed the COVID-19 pandemic, a United States media report said, citing a previously undisclosed American intelligence document that could add weight to growing calls for a full scale probe of whether the coronavirus may have escaped from China's top bio lab.

Indian scientists develop low-cost COVID-19 test, Feluda

Indian scientists develop low-cost COVID-19 test, Feluda

Rediff.com22 Apr 2020

Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

Heart, BP patients likely to be infected with COVID-19 again: Study

Heart, BP patients likely to be infected with COVID-19 again: Study

Rediff.com24 Jun 2020

Researchers from Huazhong University of Science and Technology in China assessed data on 938 COVID-19 patients from the country's Wuhan Union Hospital. They obtained information about residual symptoms in these patients, and the results of follow up tests for viral genetic material in their body after they were discharged.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

Reliance proposes using tapeworm drug to treat Covid patients

Reliance proposes using tapeworm drug to treat Covid patients

Rediff.com3 Jun 2021

Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.

Omicron study: Sputnik V and Light booster effective

Omicron study: Sputnik V and Light booster effective

Rediff.com22 Dec 2021

Russia's Sputnik V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the highly-contagious Omicron variant of COVID-19, providing a strong defence against severe disease and hospitalisation, according to a study.

Aerosols carrying Covid virus can travel in air up to 10m: Centre

Aerosols carrying Covid virus can travel in air up to 10m: Centre

Rediff.com21 May 2021

Nasal droplets fall within 2 metres from a COVID-19 infected person and the aerosols can travel in air up to 10 metres, the Office of the Principal Scientific Adviser said on Thursday, adding that proper ventilation can decrease the risk of transmission.

IIT study finds Covid traces in Sabarmati river, 2 lakes

IIT study finds Covid traces in Sabarmati river, 2 lakes

Rediff.com18 Jun 2021

A recent study by researchers at the Indian Institute of Technology (IIT) Gandhinagar has established the presence of coronavirus in water samples from the Sabarmati river and two lakes in Ahmedabad city of Gujarat.

When you engineer a virus, you leave behind...'

When you engineer a virus, you leave behind...'

Rediff.com29 Jun 2021

'...signatures.' 'But such signatures are missing in this virus.'

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.

Biological E ties up with US-based Baylor for Covid vaccine

Biological E ties up with US-based Baylor for Covid vaccine

Rediff.com28 Aug 2020

According to BCM, Hyderabad-headquartered BE has licensed the recombinant protein Covid-19 vaccine candidate developed at Baylor.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

Rediff.com25 Sep 2021

Prime Minister Narendra Modi, in his address at the 76th session of the United Nations General Assembly on Saturday, invited the global manufacturers of vaccines to come and make vaccines in India, stressing that the country's "faith is to serve people".

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

Cambridge kicks off vaccine race to fight all coronaviruses

Cambridge kicks off vaccine race to fight all coronaviruses

Rediff.com26 Aug 2020

The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of many relatives of human coronaviruses.

Bharat Biotech to make 900 million Covaxin vaccines

Bharat Biotech to make 900 million Covaxin vaccines

Rediff.com1 Jun 2021

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.

Can Wastewater Testing tell us more about COVID-19?

Can Wastewater Testing tell us more about COVID-19?

Rediff.com6 Jul 2020

'Wastewater containing excreted material can tell us how a community is doing in a particular area pertaining to any epidemic, pandemic, and other bacterial and viral diseases.'

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

Is this Indian Covid vaccine better than Pfizer's?

Is this Indian Covid vaccine better than Pfizer's?

Rediff.com12 Dec 2020

India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.

Countdown begins for launch of ISRO's foreign satellites

Countdown begins for launch of ISRO's foreign satellites

Rediff.com15 Sep 2018

This would be the 44th flight of the PSLV and the third launch by ISRO this year.